COVID-19
University of Miami Leads a Pilot Program to Track Variants of COVID-19
Feb. 26 2021 | Share
coronavirus
COVID-19
Sylvester Researcher Finds FDA-Approved Antiviral Drug Can Be Delivered Via Nanoparticle for COVID-19
A Sylvester Comprehensive Cancer Center researcher at the University of Miami Miller School of Medicine has found that an orally administered nanoparticle can deliver the FDA-approved drug Ivermectin to suppress the COVID-19 virus. “Our…
COVID-19
Teamwork Scores a Big Win for COVID-19 Testing
The first cases of COVID-19 occurred in Wuhan, China, and were reported globally by Chinese health authorities on December 31, 2019. The first confirmed cases in the United States were…
COVID-19
A UHealth Tower COVID-19 Patient Is Now Recovering at Home
Back in March, Rabbi Sholom D. Lipskar was fighting for his life in the intensive care unit of UHealth Tower, the flagship hospital of the University of Miami Health System.…